Loading stock data...

Kwality Pharmaceuticals Limited

BSE: KPL

BSE
1,124.45 -20.45 (-1.79%)

Prev Close

1144.9

Open Price

1141

Volume

8,537

Today Low / High

1119.25 / 1149.95

52 WK Low / High

596.05 / 1235

Range

1,068 - 1,181

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 1124.45, reflecting a change of -20.45 (-1.78618%). The expected target range on the BSE is 1,068 - 1,181. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

01 Aug 1,141.00 -1.45%
31 Jul 1,119.00 2.31%
30 Jul 1,157.10 -0.40%
29 Jul 1,109.95 5.37%
28 Jul 1,174.00 -5.87%
25 Jul 1,198.95 -2.51%
24 Jul 1,138.00 4.86%
23 Jul 1,159.80 -2.67%
22 Jul 1,153.90 -0.82%
21 Jul 1,177.95 -2.81%
18 Jul 1,192.00 -2.32%
17 Jul 1,188.95 -0.35%
16 Jul 1,200.00 -2.95%
15 Jul 1,175.95 1.58%
14 Jul 1,174.90 0.09%
11 Jul 1,188.95 -0.18%
10 Jul 1,157.95 0.83%
09 Jul 1,187.00 -3.64%
08 Jul 1,175.90 -0.35%
07 Jul 1,199.90 -2.71%

Kwality Pharmaceuticals Limited Graph

Kwality Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Kwality Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,124.45, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 1,124.45 1,135.69 1,022.13 - 1,249.26
1,146.94 917.55 - 1,376.33
1,158.18 810.73 - 1,505.64
Bearish Scenario 1,124.45 1,113.21 1,001.88 - 1,224.53
1,101.96 881.57 - 1,322.35
1,090.72 763.50 - 1,417.93

Overview of Kwality Pharmaceuticals Limited

ISIN

INE552U01010

Industry

Medical - Pharmaceuticals

Vol.Avg

29,163

Market Cap

11,667,518,090

Last Dividend

0

Official Website

Visit Website

IPO Date

2016-07-18

DCF Diff

636.29

DCF

488

Financial Ratios Every Investor Needs

Stock Dividend of KPL

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2017-01-05 January 05, 17 0.3 0.6

Stock Rating Details for KPL

Metric Value Recommendation
Overall Rating B+ Neutral
DCF Score 3 Neutral
ROE Score 4 Buy
ROA Score 5 Strong Buy
Debt-to-Equity (DE) Score 2 Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 2 Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 370.20 Cr 182.49 Cr 187.71 Cr 0.5071 0.00 Cr 0.00 Cr 143.93 Cr 39.85 Cr 38.36 82.31 Cr 0.1076
2024-03-31 307.17 Cr 163.47 Cr 143.70 Cr 0.4678 0.00 Cr 4.81 Cr 46.79 Cr 23.80 Cr 22.93 61.04 Cr 0.0775
2023-03-31 251.03 Cr 119.54 Cr 131.49 Cr 0.5238 0.00 Cr 6.93 Cr 48.08 Cr 19.37 Cr 18.67 47.14 Cr 0.0772
2022-03-31 456.19 Cr 210.19 Cr 245.99 Cr 0.5392 0.00 Cr 3.51 Cr 162.91 Cr 119.99 Cr 115.64 175.17 Cr 0.2630
2021-03-31 262.01 Cr 171.33 Cr 90.68 Cr 0.3461 0.00 Cr 2.78 Cr 23.96 Cr 15.15 Cr 14.60 30.44 Cr 0.0578

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 14.76 Cr 447.27 Cr 184.88 Cr 264.0483 Cr 112.45 Cr 97.69 Cr 83.47 Cr 143.98 Cr 0.00 Cr 0.00 Cr 0.00 Cr 169.5050 Cr
2024-03-31 2.26 Cr 394.21 Cr 171.63 Cr 224.2114 Cr 98.12 Cr 95.86 Cr 78.39 Cr 150.43 Cr 18.48 Cr 0.00 Cr 0.00 Cr 151.8501 Cr
2023-03-31 3.07 Cr 353.63 Cr 154.56 Cr 200.5165 Cr 90.26 Cr 87.19 Cr 86.31 Cr 134.79 Cr 18.53 Cr 0.00 Cr 0.93 Cr 125.9457 Cr
2022-03-31 9.13 Cr 340.59 Cr 160.80 Cr 181.1441 Cr 54.01 Cr 44.88 Cr 53.36 Cr 103.88 Cr 17.85 Cr 9.18 Cr 8.46 Cr 139.4861 Cr
2021-03-31 5.81 Cr 166.26 Cr 106.41 Cr 61.1526 Cr 41.23 Cr 35.42 Cr 17.36 Cr 59.42 Cr 20.93 Cr 9.18 Cr 0.73 Cr 78.2905 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 52.7178 Cr -28.5152 Cr -14.4404 Cr 29.4251 Cr 9.7623 Cr 12.0202 Cr -23.2927 Cr 39.8451 Cr -4.5624 Cr 0.0000 Cr -5.0783 Cr
2024-03-31 42.9828 Cr -26.3966 Cr -17.3978 Cr 13.1417 Cr -0.8117 Cr 2.2579 Cr -30.6379 Cr 31.0989 Cr -7.2025 Cr 0.0000 Cr 2.7349 Cr
2023-03-31 41.3817 Cr -48.4408 Cr 0.9941 Cr -6.2915 Cr -6.0650 Cr 3.0696 Cr -47.6732 Cr 25.5724 Cr 0.9941 Cr 0.0000 Cr -32.9544 Cr
2022-03-31 60.5969 Cr -62.9276 Cr 5.6567 Cr 5.4445 Cr 3.3261 Cr 9.1346 Cr -55.1524 Cr 161.5668 Cr 8.5740 Cr 0.0000 Cr -35.9957 Cr
2021-03-31 26.7054 Cr -23.2026 Cr 0.7673 Cr 3.3059 Cr 4.2701 Cr 5.8085 Cr -23.3995 Cr 21.2716 Cr 3.4389 Cr 0.0000 Cr 5.0523 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 115.68 Cr 60.79 Cr 54.89 Cr 0.4745 42.20 Cr 14.49 Cr 13.95 26.14 Cr 0.1253
2024-12-31 84.41 Cr 38.73 Cr 45.68 Cr 0.5412 12.94 Cr 8.53 Cr 8.22 18.15 Cr 0.1011
2024-09-30 90.03 Cr 58.88 Cr 31.16 Cr 0.3460 15.04 Cr 8.47 Cr 8.16 19.88 Cr 0.0941
2024-06-30 80.08 Cr 52.77 Cr 27.31 Cr 0.3411 13.32 Cr 8.36 Cr 8.05 17.62 Cr 0.1044
2024-03-31 91.98 Cr 60.10 Cr 31.88 Cr 0.3466 15.56 Cr 4.45 Cr 4.08 14.11 Cr 0.0483

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 14.76 Cr 0.00 Cr 14.76 Cr 154.31 Cr 83.47 Cr 283.78 Cr 143.98 Cr 447.27 Cr 184.88 Cr
2024-12-31 0.00 Cr 0.00 Cr 7.76 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -239.38 Cr
2024-09-30 3.10 Cr 4.67 Cr 7.76 Cr 113.26 Cr 83.14 Cr 242.94 Cr 137.73 Cr 393.50 Cr 154.11 Cr
2024-06-30 0.00 Cr 0.00 Cr 5.94 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -222.58 Cr
2024-03-31 5.94 Cr 20.08 Cr 5.94 Cr 131.04 Cr 78.39 Cr 242.69 Cr 139.05 Cr 394.21 Cr 171.63 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 14.49 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 8.53 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 8.47 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 8.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 4.45 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2017-10-11 October 11, 17 2:1

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹915.25 ₹109,595,165,155.00 ₹130,411.00

Key Executives

Whole Time Director
Ms. Geeta Arora

Gender: female

Year Born: 1970

Whole Time Director
Mr. Ajay Kumar Arora

Gender: male

Year Born: 1968

Chief Domestic Sales Officer
Mr. Shankar Dayal

Gender: male

Year Born: 1985

MD & Director
Mr. Ramesh Arora

Gender: male

Year Born: 1954

Whole Time Director
Ms. Anju Arora

Gender: female

Year Born: 1962

Company Secretary & Compliance Officer
Ms. Gurpreet Kaur

Gender: female

Year Born:

Chief Financial Officer & Whole Time Director
Mr. Aditya Arora

Gender: male

Year Born: 1994

FAQs about Kwality Pharmaceuticals Limited

Who is the CEO of the company?

The CEO is Ramesh Arora.

What is the current market price of the stock?

The current price is ₹1,124.45.

What is the 52-week price range?

The range is ₹596.05-1235.

What is the market capitalization of the company?

The market capitalization is ₹1,166.75 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 29.31.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Kwality Pharmaceuticals Limited (ISIN: INE552U01010) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹1,166.75 crores and an average daily volume of 29,163 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack